1[1]Langendijk JA,Leemans CR,Buter J,Berkhof J,Slotman BJ.The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma:a meta-analysis of the published literature.J Clin Oncol.2004,22(22):4604-4612. 被引量：1
2[2]Pignon JP BJ,Domenge C.Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:Three meta-analyses of updated individual data.Lancet.2000;355:949-955. 被引量：1
3[3]AJ M.An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer.Br J Cancer.1995;71:83-91. 被引量：1
4[4]El-Sayed S NN.Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region:A meta-analysis of prospective and randomized trials.J Clin Oncol.1996;14:838-847. 被引量：1
5[5]Bourhis J AC,Pignon JP.Update of MACH-NC(meta-analysis of chemotherapy in head & neck cancer)database focused on concomitant chemoradiotherapy.Proc Am Soc Clin Oncol,2004(abstr). 被引量：1
6[6]Rebecca WO RM.Combined chemotherapy and radiotherapy(without surgery)compared with radiotherapy alone in localized carcinoma of the esophagus.Cochrane Database Syst Rev CD002092,2003. 被引量：1
7[7]Al-Sarraf M,LeBlanc M,Giri PG,Fu KK,Cooper J,Vuong T,et al.Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer:phase III randomized Intergroup study 0099.J Clin Oncol,1998,16(4):1307-1310. 被引量：1
8[8]Edward Chowb DP,Brian O'Sullivana.Radiotherapy alone in patients with advanced nasopharyngeal cancer:comparison with an intergroup study.Radiotherapy and Oncology,2002,63(3):269-274. 被引量：1
9[9]Wee J,Tan EH,Tai BC,Wong HB,Leong SS,Tan T,et al.Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety.J Clin Oncol,2005,23(27):6730-6738. 被引量：1
10[10]Lee AW,Lau WH,Tung SY,Chua DT,Chappell R,Xu L,et al.Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma:NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group.J Clin Oncol,2005,23(28):6966-6975. 被引量：1
7Minsky BD, Pajak T, Ginsberg RJ, et al. INT 0123 ( RTOG94-05 ) phase Ⅲ trial of combined modality therapy for esophageal cancer: high dose ( 64.8 Gy) vs standard dose ( 50.4 Gy ) radiation therapy [ J]. J Clin Oncol,2002,20 (9) : 1167-1174. 被引量：1
8Bhansali MS, Fujita H, Kakegawa T,et al. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus [J]. World J Surg,1997,21 (8) :275-282. 被引量：1
9Vermund H, Pories WJ, Hillard J, et al. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer [ J]. Acta Oncol,2001,40(5 ) :558-565. 被引量：1
10$tockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus[J]. Acta Oncol,2001,40(5 ) :566-573. 被引量：1
